Core Insights - The Joint Corp. is transitioning to a pure play franchisor model, with 92% of its clinics now franchised, and has acquired rights to the Northwest regional developer territory [4][6]. Financial Highlights - Revenue for Q2 2025 increased by 5% to $13.3 million compared to $12.6 million in Q2 2024 [6][8]. - System-wide sales rose by 2.6% to $129.6 million, with comparable sales reporting a growth of 1.4% [8]. - Consolidated net income was $93,000, a significant improvement from a net loss of $3.6 million in Q2 2024 [8][9]. - Adjusted EBITDA for consolidated operations increased by 52% to $3.2 million, while Adjusted EBITDA from continuing operations improved to $88,000 from a loss of $380,000 in Q2 2024 [8][9]. Operating Highlights - The company refranchised 37 clinics for $11.2 million and sold 13 franchise licenses in Q2 2025, compared to seven sold in Q2 2024 [8]. - The clinic count reached 967 as of June 30, 2025, with 885 franchised and 82 corporate clinics [8]. Cost Management - Selling and marketing expenses increased by 1% to $3.5 million, driven by digital marketing transformation efforts [7]. - General and administrative expenses decreased by 1% to $7.7 million due to cost reduction efforts related to refranchising [7]. Balance Sheet and Cash Flow - Unrestricted cash was $29.8 million at June 30, 2025, up from $25.1 million at the end of 2024 [10]. 2025 Guidance - The company revised its guidance for system-wide sales to range from $530 million to $550 million, down from $550 million to $570 million [16]. - Expected comp sales for clinics open 13 months or more are now projected to be in the low-single digit range [16]. - Consolidated Adjusted EBITDA guidance has been increased to a range of $10.8 million to $11.8 million [16].

Core Viewpoint - The Joint Corp. plans to restate its previously issued financial statements for 2024 and the first quarter of 2025 due to errors related to the impairment of assets held for sale, which will affect the reported net loss and carrying value of these assets [1][2][4][6]. Financial Impact - For the year ended December 31, 2024, the correction is expected to reduce the previously reported loss from discontinued operations by approximately $2.2 million, leading to a decrease in net loss and an increase in the carrying value of assets held for sale by the same amount [4]. - For the quarter ended March 31, 2025, the correction is anticipated to increase previously reported income from discontinued operations by approximately $0.5 million, resulting in a cumulative increase in the carrying value of assets held for sale by approximately $2.7 million [6]. Adjusted EBITDA - The adjustments for both the year ended December 31, 2024, and the quarter ended March 31, 2025, are not expected to impact Adjusted EBITDA or cash positions [5][7]. Internal Controls - The company is evaluating the impact of the identified errors on its internal control over financial reporting, expecting to conclude that there will be a material weakness in these controls during the applicable periods [8]. Company Overview - The Joint Corp. is the largest franchisor of chiropractic care in the U.S., operating over 950 locations and facilitating more than 14 million patient visits annually [10]. - The company has been recognized in various industry rankings, including Franchise Times' "Top 400" and Entrepreneur's "Franchise 500" [10]. Business Structure - The Joint Corp. operates as a franchisor and manages clinics in several states, providing management services to affiliated chiropractic practices [11].

Core Insights - The Joint Corp. will report its second quarter 2025 financial results on August 7, 2025, after market close, with a conference call scheduled for 5:00 p.m. EDT to discuss the results [1][2]. Company Overview - The Joint Corp. is the largest franchisor of chiropractic care in the U.S., operating through The Joint Chiropractic network, with over 950 locations and more than 14 million patient visits annually [4]. - The company has revolutionized access to chiropractic care since introducing its retail healthcare business model in 2010, making quality care convenient and affordable without the need for insurance [4]. - The Joint Corp. has received multiple accolades, including being named "No. 1 in Chiropractic Services" by Entrepreneur and consistently ranking in Franchise Times' annual lists [4]. Business Structure - The Joint Corp. operates as a franchisor of clinics and also manages clinics in certain states, providing management services to affiliated professional chiropractic practices in various states [5].

Core Insights - The Joint Corp. has sold 31 corporate-owned clinics in Arizona and New Mexico for $8.3 million, along with acquiring regional developer rights that generated $855,000 in royalties and franchise fees over the past year [1][2] Group 1: Business Strategy - The refranchising initiative aims to strengthen and simplify the business while ensuring clinics are operated by proven franchise operators [2] - The acquisition of regional developer rights is expected to reduce commission obligations and increase operating margins, as these clinics incurred $855,000 in royalties and commissions in the last twelve months [2] Group 2: Company Overview - The Joint Corp. is the largest franchisor of chiropractic care in the U.S., with over 950 locations and more than 14 million patient visits annually [4] - The company has been recognized in various franchise rankings, including being named "No. 1 in Chiropractic Services" by Entrepreneur [4] Group 3: Operational Structure - The Joint Corp. operates as both a franchisor and operator of clinics in several states, providing management services to affiliated chiropractic practices [5]

Core Insights - The Joint Corp. has appointed Scott J. Bowman as the new Chief Financial Officer, effective June 10, 2025, replacing Jake Singleton [3][4] - Bowman's extensive experience includes serving as CFO for multiple publicly traded companies and is expected to drive the company's strategic initiatives [4][5] - The company aims to execute a multiphase strategy focused on growth, overhead reduction, and profitability improvement [4][5] Company Overview - The Joint Corp. is the largest provider of chiropractic care in the U.S., operating through The Joint Chiropractic network [7][8] - The company has over 950 locations nationwide and records more than 14 million patient visits annually [8] - The Joint Chiropractic is recognized as a leader in the chiropractic industry, consistently appearing on various franchise rankings [8] Leadership Background - Scott J. Bowman has over 30 years of experience in finance, having served as CFO at several notable companies, including Leslie's Inc. and Dave & Buster's [5][6] - He holds a B.S. in Accounting and Finance and an MBA, along with a CPA designation [6]

Summary of The Joint Corp (JYNT) FY Conference Call Company Overview - **Company Name**: The Joint Corp (operating as The Joint Chiropractic) - **Established**: 1999 - **Business Model**: National chain of chiropractic clinics with a focus on affordable, routine chiropractic care - **Number of Clinics**: Approximately 1,000 clinics across 41 states in the U.S. [5][6] - **Unique Proposition**: No appointment necessary, open weekends and evenings, portable treatment plans, and a cash-based self-pay model [6][8] Financial Highlights - **Revenue Model**: 85% of revenue from membership plans, with a cost per adjustment lower than typical co-pays [8] - **Market Size**: The chiropractic care market in the U.S. is over $20 billion, with The Joint operating in the self-pay segment valued at approximately $8.5 billion [9] - **Franchise Model**: Clinics can be opened for $200,000 to $250,000, with average clinic volumes around $600,000 [10] Strategic Shift to Franchise Model - **Transition**: The company is moving to a fully franchised model, selling 25 corporate clinics to franchise operators [14][15] - **Rationale**: Franchise operators are expected to manage clinics more effectively and bring in fresh capital, while the company can restructure overhead for improved profitability [15][17] - **Expected Outcomes**: Anticipated emergence as a more profitable company by 2026, with a focus on reducing general and administrative costs [20][21] Growth Prospects - **Unit Growth Potential**: Current estimate of 1,950 clinics in the U.S., indicating significant growth potential [26] - **Franchisee Profile**: 90% of franchisees operate multiple clinics, with 30% being chiropractors and 70% entrepreneurs [22][23] Revenue Growth Strategies - **New Patient Acquisition**: Shift in marketing focus to pain-centric messaging, increased brand awareness, and search engine optimization [30][32] - **Lifetime Value Extension**: Launch of a mobile app to enhance patient engagement and retention [34] - **Dynamic Pricing Strategy**: Introduction of incremental pricing adjustments to offset inflation and improve clinic-level margins [35][42] Market Dynamics and Consumer Behavior - **Chiropractor Supply**: Annual output from chiropractic schools is stable at approximately 10,600 to 11,300 graduates, not limiting growth [37] - **Consumer Trends**: Increased acceptance of chiropractic care, with nearly 1 million new patients in the last year, including 350,000 new to chiropractic [52][53] - **Impact of Economic Conditions**: Short-term softening in new patient acquisition due to consumer market uncertainty, but existing patient retention remains stable [54][55] Financial Position and Capital Allocation - **Current Financials**: $22 million in cash with no debt, indicating a strong balance sheet [61] - **Stock Repurchase Program**: Announcement of a $5 million stock repurchase program to return value to shareholders [62] Conclusion - The Joint Corp is strategically positioning itself for growth through a franchise model, focusing on enhancing profitability, expanding clinic numbers, and adapting to market dynamics while maintaining a strong financial position.

Core Insights - The Joint Corp. appointed Sandi Karrmann as a Director to enhance its core operations, drive growth, and improve profitability [1][2] - Karrmann's extensive experience in human resources within the healthcare and franchise sectors is expected to contribute significantly to the company's strategic priorities for 2025 [2][3] Company Overview - The Joint Corp. is the largest provider of chiropractic care in the U.S., operating over 950 locations and facilitating more than 14 million patient visits annually [5] - The company has revolutionized access to chiropractic care through a retail healthcare business model introduced in 2010, eliminating the need for insurance [5][6] - The Joint Chiropractic is recognized in various industry rankings, including Franchise Times' "Top 400" and Entrepreneur's "Franchise 500" [5] Leadership and Strategic Focus - Sandi Karrmann has over 20 years of experience in human resources, having held senior roles at Kimberly-Clark, Tenet Healthcare, and Yum! Restaurants International [3][4] - The company aims to focus on nurturing talent, strengthening employee engagement, and retaining top chiropractic professionals as part of its growth strategy [2][5]

Core Insights - The Joint Corp. has elected Christopher M. Grandpre to its board of directors to support long-term growth objectives including new clinic openings, system-wide sales, comparable sales, and Adjusted EBITDA [1][2] Company Overview - The Joint Corp. is the largest provider of chiropractic care in the U.S. through The Joint Chiropractic network, focusing on making chiropractic care accessible and affordable without the need for insurance [5] - The company operates over 950 locations nationwide and has more than 14 million patient visits annually, positioning itself as a leader in the chiropractic industry [5] Leadership and Expertise - Christopher M. Grandpre brings over 30 years of experience in multi-branded franchise companies and M&A investment banking, having served as chairman of Empower Brands, which has sales exceeding $1.5 billion [3][4] - Grandpre's background includes founding Outdoor Living Brands and holding executive roles at various financial institutions, providing a unique perspective to The Joint's leadership [3][4] Business Model and Strategy - The Joint Corp. revolutionized chiropractic care access with its retail healthcare business model introduced in 2010, focusing on convenience and affordability for patients [5] - The company is recognized in various industry rankings, including Franchise Times' "Top 400" and Entrepreneur's "Franchise 500," highlighting its growth and innovation in the franchise sector [5]

Financial Data and Key Metrics Changes - System wide sales for Q1 2025 were $132.6 million, up 5% compared to Q1 2024, indicating resilience in the current economic environment [10] - Revenue from continuing operations increased by 7% to $13.1 million from $12.2 million in Q1 2024 [27] - Adjusted EBITDA from continuing operations was $46,000, a significant decrease from $425,000 in Q1 2024 [10][29] - Net loss from continuing operations was $506,000, compared to a loss of $399,000 in Q1 2024 [29] Business Line Data and Key Metrics Changes - Comp sales for all clinics open for at least 13 months were up 3% for Q1 2025 and increased to 4% in March 2025 [10][23] - Comp sales for mature clinics (open for at least 48 months) were down 2% [23] - The company refranchised two corporate clinics and opened five franchise clinics during Q1 2025, with a total of 969 clinics, of which 847 (87%) are franchise clinics [25] Market Data and Key Metrics Changes - The company is experiencing a dynamic consumer environment, with consumer sentiment affecting new patient volumes [11][43] - The company anticipates system wide sales for 2025 to be between $550 million and $570 million, compared to $530.3 million in 2024 [31] Company Strategy and Development Direction - The company aims to become a pure play franchisor, with 93% of corporate clinics under Letters of Intent (LOIs) for refranchising [12][49] - The focus is on strengthening core operations, reigniting growth, and improving profitability through dynamic revenue management and enhanced digital marketing strategies [12][18] - The company plans to launch a new marketing campaign centered around pain relief in the second half of the year [36] Management's Comments on Operating Environment and Future Outlook - Management acknowledges the impact of economic headwinds, inflation, and consumer sentiment on operations but remains optimistic about transitioning to a franchise model [33] - The company expects to see a transformative financial impact as corporate clinics transition to franchise royalties and fees, leading to increased profitability [33] Other Important Information - The company has welcomed new executives to enhance legal strategy and patient experience [39] - The Joint has been recognized as one of the fastest-growing franchises and ranked 37th in the Franchise 500 by Entrepreneur Magazine [40] Q&A Session Summary Question: New patient ad metrics and retention trends - Management noted that new patient volumes have been affected by consumer sentiment, but retention rates remain stable [42][44] Question: Metrics on profitability and overhead reduction - Management is not ready to provide specific metrics but expects profitability to improve as G&A expenses are reduced [45][47] Question: Timeline for refranchising process completion - Management intends to exit 2025 as a pure play franchisor and hopes to accelerate the refranchising process [49] Question: Comp sales performance and strategies for mature clinics - Comp sales for mature clinics have been consistent, and operational strategies will be geared towards strengthening these clinics [80][81] Question: Dynamic pricing impact - Management is exploring various pricing models and anticipates that pricing adjustments could significantly impact total system wide sales [60][62] Question: Selling and marketing expenses normalization - Management expects selling and marketing expenses to normalize by Q3 2025 as the transition to a single marketing agency is completed [66] Question: Cost of the franchisee spring convention - The cost of the convention was lower than previous years, impacting the sales and marketing line [75][76]

Core Insights - The Joint Corp. is strengthening its leadership team to enhance company core, reignite growth, and improve profitability [1] Leadership Appointments - Andra J. Terrell has been appointed as Senior Vice President Legal, bringing 20 years of experience in franchising legal matters, compliance strategy, and complex transactions [2][5] - Eric Wyatt has been appointed as Senior Vice President Operations and Patient Experience, with over 30 years of experience in franchise operations and general management [4][5] Company Overview - The Joint Corp. is the largest provider of chiropractic care in the U.S., operating over 950 locations and achieving more than 14 million patient visits annually [7] - The company has been recognized in various rankings, including Franchise Times' "Top 400" and "Fast & Serious" lists, and was named "No. 1 in Chiropractic Services" by Entrepreneur [7] Business Structure - The Joint Corp. operates as a franchisor of clinics and provides management services to affiliated chiropractic practices in several states [8]